Portrait happy young woman sitting on grass in park writing in book and looking away

Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2023)

Start
In its recent review of a district court decision the Federal Circuit characterized as “a thorough opinion,” the Federal Circuit affirmed invalidation for obviousness of four claims from four different Orange Book-listed patents in Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc….
By: McDonnell Boehnen Hulbert & Berghoff LLP
Previous Story

FTC Issues Policy Statement Regarding Biometric Information

Next Story

Trade Secrets and Generative AI: Protective Measures In an Evolving Technological Landscape